Literature DB >> 16631014

Transthyretin V122I in African Americans with congestive heart failure.

Joel Buxbaum, Daniel R Jacobson, Clement Tagoe, Alice Alexander, Dalane W Kitzman, Barry Greenberg, Surai Thaneemit-Chen, Philip Lavori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16631014     DOI： 10.1016/j.jacc.2006.01.042

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  25 in total

Review 1.  Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.

Authors:  Frederick L Ruberg; Martha Grogan; Mazen Hanna; Jeffery W Kelly; Mathew S Maurer
Journal:  J Am Coll Cardiol       Date:  2019-06-11       Impact factor: 24.094

2.  The Missing Diversity in Human Genetic Studies.

Authors:  Giorgio Sirugo; Scott M Williams; Sarah A Tishkoff
Journal:  Cell       Date:  2019-05-02       Impact factor: 41.582

3.  Age-related oxidative modifications of transthyretin modulate its amyloidogenicity.

Authors:  Lei Zhao; Joel N Buxbaum; Natàlia Reixach
Journal:  Biochemistry       Date:  2013-03-04       Impact factor: 3.162

4.  Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.

Authors:  Joel Buxbaum; Alice Alexander; James Koziol; Clement Tagoe; Ervin Fox; Dalane Kitzman
Journal:  Am Heart J       Date:  2010-05       Impact factor: 4.749

Review 5.  Transthyretin Cardiac Amyloidosis in Black Americans.

Authors:  Keyur B Shah; Anit K Mankad; Adam Castano; Olakunle O Akinboboye; Phillip B Duncan; Icilma V Fergus; Mathew S Maurer
Journal:  Circ Heart Fail       Date:  2016-06       Impact factor: 8.790

Review 6.  Transthyretin Cardiac Amyloidosis.

Authors:  Anit K Mankad; Keyur B Shah
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

Review 7.  Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.

Authors:  Mathew S Maurer; Sabahat Bokhari; Thibaud Damy; Sharmila Dorbala; Brian M Drachman; Marianna Fontana; Martha Grogan; Arnt V Kristen; Isabelle Lousada; Jose Nativi-Nicolau; Candida Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Ronald Witteles; Giampaolo Merlini
Journal:  Circ Heart Fail       Date:  2019-09-04       Impact factor: 8.790

Review 8.  Emerging Advances in the Management of Cardiac Amyloidosis.

Authors:  Michael N Vranian; Brett W Sperry; Jason Valent; Mazen Hanna
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

9.  ATF6 activation reduces the secretion and extracellular aggregation of destabilized variants of an amyloidogenic protein.

Authors:  John J Chen; Joseph C Genereux; Song Qu; John D Hulleman; Matthew D Shoulders; R Luke Wiseman
Journal:  Chem Biol       Date:  2014-10-23

Review 10.  Novel drugs targeting transthyretin amyloidosis.

Authors:  Mazen Hanna
Journal:  Curr Heart Fail Rep       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.